Clinical Trials
161 trialsNCT02386137 2026-05-14
PERAGUS
University Hospital, Bordeaux
Phase NA Completed
NCT04756037 2026-05-13
SERENE
Sumitomo Pharma Switzerland GmbH
Phase 3 Completed
NCT05409872 2026-05-05
DEFIB
Universita di Verona
Phase NA Completed
NCT07384468 2026-02-03
SGB-PROP-PIA
Cangzhou Central Hospital
Phase NA Completed
NCT04655144 2026-01-07
Dex-Fib
University of Miami
Phase 3 Completed
NCT06429163 2026-01-06
WINPLEX
Saint Petersburg State University, Russia
Phase NA Completed
NCT07046949 2025-12-16
Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies
Yuri Semenyuk Rivne Regional Clinical Hospital
Phase NA Completed
NCT04145518 2025-12-12
MCUP
Endeavor Health
Phase 4 Completed
NCT05445167 2025-11-25
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02577055 2025-11-20
Lune2
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT04272086 2025-11-12
Utility of Liposomal Bupivacaine Transversus Abdominal Plane Block for Open Myomectomy
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT06949124 2025-09-10
A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT06969664 2025-08-19
A Trial of SHR7280 in Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT07094633 2025-07-30
Comparative Effects of Kegel Versus Clamshell Exercises on Low Back Pain in Women With Uterine Fibroids: A Randomized Clinical Trial
University of Faisalabad
Phase NA Completed
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed
NCT05440383 2025-03-14
A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Kissei Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT04434066 2024-11-08
Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy
University of Texas Southwestern Medical Center
Phase NA Completed
NCT02777203 2024-10-24
Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy
Wake Forest University Health Sciences
Phase NA Completed
NCT05518812 2024-09-19
Carboprost (Hemabate) for Fibroid Resection
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00290251 2024-07-15
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03323905 2024-07-09
HIFUSB
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT05517590 2024-05-24
Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.
Acibadem University
Phase NA Completed
NCT03412890 2024-05-09
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT01865929 2024-03-04
Minimally Invasive Benign Hysterectomy
Region Skane
Phase NA Completed
NCT03815344 2024-01-09
Combined Vaginal Misoprostol and Perivascular Vasopressin
Maimonides Medical Center
Phase 4 Completed
NCT05868057 2023-12-08
A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT04345003 2023-12-07
ELASTUS
University Hospital, Bordeaux
Phase NA Completed
NCT04996498 2023-11-07
oxytocin
Ain Shams Maternity Hospital
Phase NA Completed
NCT05986266 2023-10-17
Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss
Egymedicalpedia
Phase 1 Completed
NCT00133705 2023-09-25
Trial of Mifepristone for Fibroids
University of Rochester
Phase 3 Completed
NCT05086770 2023-07-14
Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
Next Biomedical Co., Ltd.
Phase NA Completed
NCT04874246 2023-06-26
VALENTINE
Seoul National University Hospital
Phase NA Completed
NCT04177693 2023-06-05
Pharmacokinetics and Hepatic Safety of EGCG
Yale University
Phase 1 Completed
NCT04071574 2023-05-09
CS-EOSP-ICSI
Lebanese University
Phase 1/2 Completed
NCT03927651 2023-04-18
ICG to Assess Ovarian Perfusion
Northwestern University
Phase EARLY_PHASE1 Completed
NCT03985449 2023-02-28
UPFRONT
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT01563783 2023-02-01
TRUST
Acessa Health, Inc.
Phase NA Completed
NCT02620748 2022-10-13
TA
George Washington University
Phase 1 Completed
NCT05419414 2022-06-15
The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis
Istanbul University
Phase NA Completed
NCT03103087 2022-04-20
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03049735 2022-04-19
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT03886220 2022-03-31
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 4 Completed
NCT03317795 2021-12-08
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
Mayo Clinic
Phase 4 Completed
NCT00731341 2021-07-19
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
Boston Scientific Corporation
Phase NA Completed
NCT01441635 2021-07-13
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
AbbVie
Phase 2 Completed
NCT02691494 2021-07-13
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
AbbVie
Phase 3 Completed
NCT02925494 2021-07-13
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
AbbVie
Phase 3 Completed
NCT03070899 2021-06-09
PRIMROSE 1
ObsEva SA
Phase 3 Completed